Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Hruby

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
BJU International|April 29, 2022
Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groupsMatthew J Roberts, Mark D Chatfield, George Hruby, et al.
Cancers|October 13, 2021
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 25, 2018
Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary groupHester Lieng, Amy J Hayden, David R H Christie, et al.
Frontiers in Oncology|October 4, 2021
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical ReviewByeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
BJUI Compass|October 3, 2025
Real-world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experienceSamantha Shekar, Megan Crumbaker, Anthony Joshua, et al.
Physics and Imaging in Radiation Oncology|June 30, 2025
Patient-specific deep learning tracking for real-time 2D pancreas localisation in kV-guided radiotherapyAbdella M Ahmed, Levi Madden, Maegan Stewart, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 6, 2021
Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapyAsanka R Wijetunga, Terence C Chua, Christopher B Nahm, et al.
BMC Research Notes|May 9, 2015
First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data qualityGerald B Fogarty, Angela Hong, Kari Dolven-Jacobsen, et al.
European Urology Oncology|October 8, 2023
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, et al.
Pancreas|February 4, 2020
Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal AdenocarcinomaMalinda Itchins, Terence C Chua, Jennifer Arena, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
BJU International|April 29, 2022
Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groupsMatthew J Roberts, Mark D Chatfield, George Hruby, et al.
Cancers|October 13, 2021
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 25, 2018
Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary groupHester Lieng, Amy J Hayden, David R H Christie, et al.
Frontiers in Oncology|October 4, 2021
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical ReviewByeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
BJUI Compass|October 3, 2025
Real-world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experienceSamantha Shekar, Megan Crumbaker, Anthony Joshua, et al.
Physics and Imaging in Radiation Oncology|June 30, 2025
Patient-specific deep learning tracking for real-time 2D pancreas localisation in kV-guided radiotherapyAbdella M Ahmed, Levi Madden, Maegan Stewart, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 6, 2021
Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapyAsanka R Wijetunga, Terence C Chua, Christopher B Nahm, et al.
BMC Research Notes|May 9, 2015
First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data qualityGerald B Fogarty, Angela Hong, Kari Dolven-Jacobsen, et al.
European Urology Oncology|October 8, 2023
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, et al.
Pancreas|February 4, 2020
Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal AdenocarcinomaMalinda Itchins, Terence C Chua, Jennifer Arena, et al.
Pageof 13